21 Recruiting Stargardt Disease Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Stargardt Disease Studies
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
📍 RayTx Clinical Site — Bakersfield, California
View Study & Checklist ➔Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
📍 University of San Francisco — San Francisco, California
View Study & Checklist ➔An Observational Study in Children and Adults With Stargardt Disease
📍 Retina Foundation of the Southwest — Dallas, Texas
View Study & Checklist ➔Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
📍 University of San Francisco — San Francisco, California
View Study & Checklist ➔Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study
📍 Nanocope Clnical Site — Miami, Florida
View Study & Checklist ➔A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
📍 Alkeus Site — Phoenix, Arizona
View Study & Checklist ➔A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
📍 UCHealth Sue Anschutz-Rodgers Eye Center, — Aurora, Colorado
View Study & Checklist ➔Study of ALK-001 on the Progression of Stargardt Disease
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔